SCStephen P. Colegate

Stephen P. Colegate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen P. Colegate has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Cole Brokamp

    Cincinnati Children’s Hospital Medical Center

    2 shared publications
  • Emrah Gecili

    Affiliations Division of Biostatistics & Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, United States of America

    2 shared publications
  • Rhonda D. Szczesniak

    Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, United States

    2 shared publications
  • Aaron Flicker

    Cincinnati Children’s Hospital Medical Center

    1 shared publication
  • Andrew F. Beck

    University of Cincinnati College of Medicine

    1 shared publication
  • Andrew Finkel Beck

    Division of Hospital Medicine Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

    1 shared publication

Latest Publications

  • Open Access

    Acute exposure to fine ambient particulate matter and pulmonary exacerbations in cystic fibrosis: A case-crossover study

    by Stephen P. Colegate, Erika Rasnick Manning, Andrew Vancil, Ziyun Wang, Marepalli Rao, Emrah Gecili, Anushka Palipana, Patrick Ryan, Rhonda D. Szczesniak, Cole Brokamp


  • Open Access

    Formulating and evaluating time series algorithms to forecast daily asthma hospital admissions

    by Stephen P. Colegate, Michael Seid, David Hartley, Aaron Flicker, Joseph Bruce, Joseph Michael, Mfonobong Udoko, Andrew F. Beck, Cole Brokamp

    Introduction: Asthma exacerbations are frequent causes of pediatric hospital admissions. We sought to develop a time series algorithm to forecast next-day daily asthma hospitalizations. Methods: Daily hospitalizations for asthma were collected at Cincinnati Children’s from January 1, 2016, to December 31, 2023. We evaluated Autoregressive Integrated Moving Average (ARIMA), Exponential Smoothing (ETS), Prophet, and Ensemble models to forecast next-day asthma hospitalizations validated on 2023 data, considering varying historical training data lengths. Forecasts were calibrated to identify days exceeding a 5% high-risk threshold of historical totals and considered multiple validation years and years before and during the COVID-19 pandemic. Results: A total of 5,593 hospital admissions were recorded for asthma. Over 2,922 days, 166 days met the 5% high-risk threshold equating to 6 or more admissions. The Ensemble (Median Absolute Percentage Error (MAPE): 46.7%; Positive Predictive Value (PPV): 0.278; Negative Predictive Value (NPV): 0.942; Area Under the ROC Curve (AUC): 0.740; Sensitivity: 0.800; Specificity: 0.656) model achieved higher accuracy of high-risk days than ARIMA (MAPE: 46.5%; PPV: 0.278; NPV: 0.942; AUC: 0.709; Sensitivity: 0.760; Specificity: 0.571), ETS (MAPE: 47.2%; PPV: 0.222; NPV: 0.939; AUC: 0.711; Sensitivity: 0.800; Specificity: 0.668), and Prophet (MAPE: 48.9%; PPV: 0.444; NPV: 0.951; AUC: 0.732; Sensitivity: 0.680; Specificity: 0.741) models. Conclusions: Our Ensemble model of mean predictions from ARIMA, ETS, and Prophet models was the most accurate in forecasting future asthma hospitalizations. Integrating forecasting techniques with clinical operations could enable proactive prevention through enhanced population care management.


  • Integrating a machine learning algorithm to forecast daily asthma hospitalizations

    by S.P. Colegate, M. Seid, D. Hartley, J. Bruce, A.F. Beck, C. Brokamp

  • Open Access

    Evaluating precision medicine tools in cystic fibrosis for racial and ethnic fairness

    by Stephen P. Colegate, Anushka Palipana, Emrah Gecili, Rhonda D. Szczesniak, Cole Brokamp

    Introduction: Patients with cystic fibrosis (CF) experience frequent episodes of acute decline in lung function called pulmonary exacerbations (PEx). An existing clinical and place-based precision medicine algorithm that accurately predicts PEx could include racial and ethnic biases in clinical and geospatial training data, leading to unintentional exacerbation of health inequities. Methods: We estimated receiver operating characteristic curves based on predictions from a nonstationary Gaussian stochastic process model for PEx within 3, 6, and 12 months among 26,392 individuals aged 6 years and above (2003–2017) from the US CF Foundation Patient Registry. We screened predictors to identify reasons for discriminatory model performance. Results: The precision medicine algorithm performed worse predicting a PEx among Black patients when compared with White patients or to patients of another race for all three prediction horizons. There was little to no difference in prediction accuracies among Hispanic and non-Hispanic patients for the same prediction horizons. Differences in F508del, smoking households, secondhand smoke exposure, primary and secondary road densities, distance and drive time to the CF center, and average number of clinical evaluations were key factors associated with race. Conclusions: Racial differences in prediction accuracies from our PEx precision medicine algorithm exist. Misclassification of future PEx was attributable to several underlying factors that correspond to race: CF mutation, location where the patient lives, and clinical awareness. Associations of our proxies with race for CF-related health outcomes can lead to systemic racism in data collection and in prediction accuracies from precision medicine algorithms constructed from it.